News | Lung Imaging | July 08, 2020

Updated USPSTF Lung Cancer Screening Guidelines

The ACR encourages efforts to expand screening, particularly among minorities and women

Changes outlined in new draft U.S. Preventive Services Task Force (USPSTF) lung cancer screening recommendations will greatly increase the number of Americans eligible for screening and help medical providers save thousands more lives each year.

Image courtesy of Cerner

July 8, 2020 — Changes outlined in new draft U.S. Preventive Services Task Force (USPSTF) lung cancer screening recommendations will greatly increase the number of Americans eligible for screening and help medical providers save thousands more lives each year, according to a new statement issued by the American College of Radiology (ACR). The American College of Radiology strongly supports the USPSTF proposal to lower the starting age for screening from 55 to 50 and the smoking history requirements from 30 pack-years to 20 pack-years. The ACR encourages efforts to expand screening — particularly among minorities and women. The College will provide further input to the USPSTF in the coming weeks.

Annual lung cancer screening with low-dose computed tomography (LDCT) in high-risk patients significantly reduces lung cancer deaths.[1],[2]  This screening can identify cancers at an early, treatable and curable stage. Given that the American Cancer Society predicts 135,720 lung cancer deaths this year, more-widespread screening could save 30,000–60,000 lives in the United States each year.

The ACR recommends that — to save more lives from lung cancer:

  1. The USPSTF should lower the starting age for screening from age 55 to age 50 and the smoking history requirements from 30 pack-years to 20 pack-years.
  2. The USPSTF should extend the quit-smoking requirement from 15 years to 20 years.
  3. Medical providers must get familiar with lung cancer screening guidelines and prescribe these exams for high-risk patients. Today, only a fraction of the recommended population is screened.

“Lung cancer kills more people each year than breast, colon and prostate cancers combined. Particularly with the new more-sensible pack-year threshold, if implemented nationwide, this cost-effective test would save more lives than any cancer-screening test in history. Primary care providers and thoracic specialists should support the proposed lower starting age and more-inclusive pack-year threshold, and order these scans for their high-risk patients,” said Debra Dyer, M.D., FACR, chair of the American College of Radiology (ACR) Lung Cancer Screening 2.0 Committee.

“It's great to see the draft USPSTF proposal extending the reach of this massive lifesaving benefit to more people at risk. The threat to older current and former smokers from this disease, means we must do all we can to ensure patients are appropriately referred and have widespread access to lung cancer screening CT. The lower starting age and broader pack-year threshold will help save more lives from the nation’s leading cancer killer,” said Ella Kazerooni M.D., MS, FACR, chair of the ACR Lung-RADS committee and Lung Cancer Screening Registry.

For more information: www.acr.org

Related Content

The research evaluates the feasibility of biology-guided radiotherapy to treat metastatic cancer
News | Radiation Therapy | October 24, 2020
October 24, 2020 — ...
AI-powered premium large bore CT scanner offers industry’s largest bore and widest field-of-view
News | Computed Tomography (CT) | October 24, 2020
October 24, 2020 — An estimated 1.8 million new cancer cases will be diagnosed in the U.S.
Be sure to register for the American Society for Radiation Oncology's (ASTRO) 62nd Annual Meeting, to be held October 24-28, 2020, via an interactive virtual platform. The meeting, Global Oncology: Radiation Therapy in a Changing World, will feature reports from the latest clinical trials; panels on global oncology, health disparities and the novel coronavirus; and an immersive attendee experience in a virtual convention center.
News | ASTRO | October 23, 2020
October 23, 2020 — Be sure to ...
IBA showcases how its Proteus solutions and its network of clinical and industrial partners are shaping the future of proton therapy
News | Proton Therapy | October 23, 2020
October 23, 2020 — IBA, a leading provider of proton thera...
RaySearch Laboratories AB will demo its latest advances in oncology software at the American Society for Radiation Oncology (ASTRO) 2020 Annual Meeting
News | Radiation Oncology | October 23, 2020
October 23, 2020 — RaySearch will present recent and upcoming enhancements, as well as new functionality, in...
Recommendations address patient selection and treatment techniques for locally advanced disease

Getty Images

News | Radiation Therapy | October 22, 2020
October 22, 2020 — A new ...
On Oct. 21, Seema Verma, administrator of the Centers for Medicare & Medicaid Services, tweeted that CMS will delay the Radiation Oncology Model’s launch from Jan. 1 to July 1 

Getty Images

News | ASTRO | October 22, 2020
October 22, 2020 — In response to the Oct.
Ezra, a NY-based startup transforming early cancer screening using magnetic resonance imaging (MRI), announced that it has received FDA 510(k) premarket authorization for its Artificial Intelligence, designed to decrease the cost of MRI-based cancer screening, assisting radiologists in their analysis of prostate MRI scans. It is the first prostate AI to be cleared by the FDA.
News | Artificial Intelligence | October 20, 2020
October 20, 2020 — Ezra, a NY-based startup transforming early cancer screening using...
Rebrand reflects Volpara Health's mission to prevent advanced-stage breast cancer
News | Breast Imaging | October 19, 2020
October 19, 2020 — Volpara Solutions, a leader in AI-powered breast density assessment, announced that it has changed
Moffitt Cancer Center researchers are developing a noninvasive, accurate method to analyze a patient's tumor mutations and biomarkers to determine the best course of treatment.

Getty Images

News | Lung Imaging | October 19, 2020
October 19, 2020 — Personalized treatment options for patients with...